These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22947056)

  • 1. The potential for selective pharmacological therapies through biased receptor signaling.
    Kenakin T
    BMC Pharmacol Toxicol; 2012 Aug; 13():3. PubMed ID: 22947056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.
    Kenakin T
    Br J Pharmacol; 2013 Feb; 168(3):554-75. PubMed ID: 22994528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling bias in new drug discovery: detection, quantification and therapeutic impact.
    Kenakin T; Christopoulos A
    Nat Rev Drug Discov; 2013 Mar; 12(3):205-16. PubMed ID: 23411724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased Receptor Signaling in Drug Discovery.
    Kenakin T
    Pharmacol Rev; 2019 Apr; 71(2):267-315. PubMed ID: 30914442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors.
    Kenakin T
    Br J Pharmacol; 2015 Sep; 172(17):4238-53. PubMed ID: 26075971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effective Application of Biased Signaling to New Drug Discovery.
    Kenakin T
    Mol Pharmacol; 2015 Dec; 88(6):1055-61. PubMed ID: 26138073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Measurement of Receptor Signaling Bias.
    Kenakin T
    Methods Mol Biol; 2015; 1335():163-76. PubMed ID: 26260600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is pharmacological 'affinity'? Relevance to biased agonism and antagonism.
    Kenakin T
    Trends Pharmacol Sci; 2014 Sep; 35(9):434-41. PubMed ID: 25042457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of Receptor Signaling Bias.
    Kenakin T
    Curr Protoc Pharmacol; 2016 Sep; 74():2.15.1-2.15.15. PubMed ID: 27636109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating biased agonists from molecules to medications: Serotonin 5-HT
    Newman-Tancredi A; Depoortère RY; Kleven MS; Kołaczkowski M; Zimmer L
    Pharmacol Ther; 2022 Jan; 229():107937. PubMed ID: 34174274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
    McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
    SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse agonism: more than reverting constitutively active receptor signaling.
    Dupré DJ; Rola-Pleszczynski M; Stanková J
    Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling bias in drug discovery.
    Kenakin T
    Expert Opin Drug Discov; 2017 Apr; 12(4):321-333. PubMed ID: 28277840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Practical Guide to Approaching Biased Agonism at G Protein Coupled Receptors.
    Gundry J; Glenn R; Alagesan P; Rajagopal S
    Front Neurosci; 2017; 11():17. PubMed ID: 28174517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying ligand bias at seven-transmembrane receptors.
    Rajagopal S; Ahn S; Rominger DH; Gowen-MacDonald W; Lam CM; Dewire SM; Violin JD; Lefkowitz RJ
    Mol Pharmacol; 2011 Sep; 80(3):367-77. PubMed ID: 21610196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrestin pathways as drug targets.
    Luttrell LM
    Prog Mol Biol Transl Sci; 2013; 118():469-97. PubMed ID: 23764065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington's Disease.
    Bagher AM; Laprairie RB; Kelly MEM; Denovan-Wright EM
    Methods Mol Biol; 2018; 1780():549-571. PubMed ID: 29856035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of β-arrestin- and G protein-biased agonists.
    Whalen EJ; Rajagopal S; Lefkowitz RJ
    Trends Mol Med; 2011 Mar; 17(3):126-39. PubMed ID: 21183406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonism: mechanisms based on ligand-receptor interactions and on stimulus-response coupling.
    Pliska V
    J Recept Signal Transduct Res; 1999; 19(1-4):597-629. PubMed ID: 10071788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional selectivity and biased receptor signaling.
    Kenakin T
    J Pharmacol Exp Ther; 2011 Feb; 336(2):296-302. PubMed ID: 21030484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.